EQS Group-News: Jacobs Holding AG
/ Schlagwort(e): Beteiligung/Unternehmensbeteiligung
NOT FOR RELEASE, PUBLICATION, CIRCULATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR IN ANY JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL Zürich, 28. April 2021 - Die Jacobs Holding AG (Jacobs Holding) hat die Platzierung von 550'000 Aktien von Barry Callebaut AG (10.0% des Aktienkapitals) über ein beschleunigtes Bookbuilding-Verfahren (das "Angebot") zu einem Preis von CHF 1'990 je Aktie erfolgreich abgeschlossen. Mit einer Beteiligung von 30,1% bleibt die Jacobs Holding Hauptaktionärin von Barry Callebaut und weiterhin in vollem Umfang an der Entwicklung des Unternehmens beteiligt, was auch eine unveränderte Vertretung im Verwaltungsrat einschliesst. Jacobs Holding hat sich für die verbleibende Beteiligung an Barry Callebaut zu einer Sperrfrist von einem Jahr nach Abschluss des Angebots verpflichtet. Credit Suisse und Goldman Sachs International fungierten bei diesem Angebot als Joint Bookrunners.
Medienkontakt Jacobs Holding: Andreas Hildenbrand, Lemongrass Communications
The offering of the shares in Switzerland is exempt from the requirement to prepare and publish a prospectus under the Swiss Financial Services Act (FinSA) because such offering is made to professional clients within the meaning of the FinSA only (article 36 para.1 lit. a FINSA). This press release does not constitute a prospectus as such term is understood pursuant to the FinSA or under any applicable laws or regulations. This announcement may contain specific forward-looking statements, e.g. statements including terms like "believe", "assume", "expect", "forecast", "project", "may", "could", "might", "will" or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties, readers should not rely on forward-looking statements. Jacobs Holding assumes no responsibility to update forward-looking statements or to adapt them to future events or developments. The information contained herein shall not constitute an offer to sell or the solicitation of an offer to buy, in any jurisdiction in which such offer or solicitation would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any jurisdiction. This announcement is not for distribution, directly or indirectly, in or into the United States (including its territories and dependencies, any state of the United States and the District of Columbia), Canada, Japan, Australia or any jurisdiction into which the same would be unlawful. This announcement does not constitute or form a part of any offer or solicitation to purchase, subscribe for or otherwise acquire securities in the United States, Canada, Japan, Australia or any jurisdiction in which such an offer or solicitation is unlawful. Barry Callebaut AG shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act") or under any securities laws of any state or other jurisdiction of the United States and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within the United States except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. There will be no public offering of securities in the United States. The Barry Callebaut shares have not been approved or disapproved by the US Securities and Exchange Commission, any state's securities commission in the United States or any US regulatory authority, nor have any of the foregoing authorities passed upon or endorsed the merits of the offering of Barry Callebaut AG shares or the accuracy or adequacy of this announcement. Any representation to the contrary is a criminal offence in the United States. The offer referred to herein, when made in member states of the European Economic Area (EEA), is only addressed to and directed to "qualified investors" within the meaning of article 2(e) the Prospectus Regulation ("Qualified Investors"). For these purposes, the expression Prospectus Regulation means Regulation (EU) 2017/1129 of the European Parliament and of the Council of June 14, 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC, and includes any relevant delegated regulations. The information contained herein does not constitute an offer of securities to the public in the United Kingdom. No prospectus offering securities to the public will be published in the United Kingdom. This document is only being distributed to and is only directed at Qualified Investors within the meaning of UK version of the Prospectus Regulation which is part of English law by virtue of the European Union (Withdrawal) Act 2018 who are (i) persons outside the United Kingdom or (ii) investment professionals falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within article 49(2)(a) to (d) of the Order (all such persons together being referred to as "relevant persons"). The securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents. Zusatzmaterial zur Meldung: Datei: Jacobs Holding BARN Pricing 20210428 Ende der Medienmitteilungen |
1189581 28.04.2021
